Open access guideline for pharma about using social media: V3

If you follow, you know we have been working on a collaborative open access guide for pharma about using social media since May. Here are the Q&As about the project. As we are approaching the end of August, it’s time to insert the final thoughts, comments and additional links about positive and negative examples for pharma using social media channels because we should have the first draft of the guides by the end of September. I hope you join us!